HomeMIRM • NASDAQ
add
Mirum Pharmaceuticals Inc
Previous close
$64.67
Day range
$64.39 - $66.77
Year range
$36.88 - $78.54
Market cap
3.40B USD
Avg Volume
625.73K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 133.01M | 47.17% |
Operating expense | 104.87M | 27.49% |
Net income | 2.90M | 120.41% |
Net profit margin | 2.18 | 113.84% |
Earnings per share | 0.05 | 116.67% |
EBITDA | 8.66M | 230.71% |
Effective tax rate | -9.91% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 375.55M | 32.03% |
Total assets | 785.12M | 17.55% |
Total liabilities | 493.07M | 13.12% |
Total equity | 292.05M | — |
Shares outstanding | 51.39M | — |
Price to book | 11.37 | — |
Return on assets | 0.86% | — |
Return on capital | 1.10% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 2.90M | 120.41% |
Cash from operations | 39.68M | 896.01% |
Cash from investing | -2.23M | 87.65% |
Cash from financing | 16.10M | 316.67% |
Net change in cash | 53.90M | 633.60% |
Free cash flow | 33.25M | 384.72% |
About
Founded
2018
Headquarters
Website
Employees
355
